Eric Zwisler

Eric Zwisler is a seasoned executive with extensive experience in healthcare distribution and governance. Currently serving as a Board Member for the Diabetes Research Connection since December 2021, Zwisler has made significant contributions to advancing Type One Diabetes research. Previous roles include Non Executive Director positions at HTDK Distribution and SQI Diagnostics and serving as Chairman of the Board for both Insect Technology Group and the La Jolla Institute for Immunology. Zwisler's leadership experience spans Cardinal Health, where Zwisler held the title of Chairman in China and was formerly the President of the healthcare distribution business after its acquisition of Zuellig Pharma China. Educational qualifications include an MBA in Strategy and General Management from the University of Michigan and a BA in Economics and Mathematics from Carroll University, along with advanced studies in Chinese Language.